289 related articles for article (PubMed ID: 9123416)
1. Acute rejection episodes predict long-term renal transplantation survival.
Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
[No Abstract] [Full Text] [Related]
2. Living unrelated kidney transplantation.
Malaise J; Mourad M; Besse T; Jamar F; Baldi A; Setola P; De Meyer M; Pirson Y; Squifflet JP
Transplant Proc; 1997 Nov; 29(7):2770-2. PubMed ID: 9365556
[No Abstract] [Full Text] [Related]
3. Cadaveric renal transplantation at University Hospital Kuala Lumpur: a preliminary report.
Tan SY; Chen TP; Lee SH; Tan PS; Chua CT; Teo SM; Thiruventhiran T; Wo M; Loh CS; Hassan A; Tan JC; Koh SN
Transplant Proc; 2000 Nov; 32(7):1811-2. PubMed ID: 11119947
[No Abstract] [Full Text] [Related]
4. Impact of delayed graft function on cadaveric kidney transplant outcome.
Gentil MA; Alcaide MP; Algarra GR; Pereira P; Toro J; González-Roncero F; López M; Bernal G; Mateos J
Transplant Proc; 2003 Mar; 35(2):689-91. PubMed ID: 12644095
[No Abstract] [Full Text] [Related]
5. Early graft dysfunction developed within one week after renal allograft.
Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
[No Abstract] [Full Text] [Related]
6. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
[No Abstract] [Full Text] [Related]
7. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood.
Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
Transplant Proc; 2001 May; 33(3):2256-7. PubMed ID: 11377520
[No Abstract] [Full Text] [Related]
9. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.
Mulloy LL; Wright F; Hall ML; Moore M
Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541
[No Abstract] [Full Text] [Related]
10. Etiology of early renal allograft dysfunction after live donor renal transplantation.
Morrissey PE; Gohh R; Madras PN; Shaffer D; Davis C; Conway P; Sahyoun A; Monaco AP
Transplant Proc; 1998 Jun; 30(4):1320. PubMed ID: 9636536
[No Abstract] [Full Text] [Related]
11. A comparative analysis of methyl prednisone pulse versus orthoclone therapy in the management of acute cellular rejection.
Nampoory MR; Johny KV; Costandi JN; al-Muzairai IM; Gupta RK; Nair MP; Samhan M; al-Mousawi M
Transplant Proc; 1997 Nov; 29(7):2967-70. PubMed ID: 9365632
[No Abstract] [Full Text] [Related]
12. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
[No Abstract] [Full Text] [Related]
13. Effect of acute rejection episodes on long-term renal graft survival.
Berczi C; Asztalos L; Kincses Z; Löcsey L; Balázs G
Transplant Proc; 1998 Aug; 30(5):1775. PubMed ID: 9723277
[No Abstract] [Full Text] [Related]
14. Kidney transplantation from living related donors.
Mouquet C; Benalia H; Barrou B; Ourahma S; Luciani J; Coriat P; Bitker MO
Transplant Proc; 1996 Oct; 28(5):2801. PubMed ID: 8908065
[No Abstract] [Full Text] [Related]
15. Accelerated acute rejection in renal allograft.
Han DJ; Yoon HS; Lee HM
Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
[No Abstract] [Full Text] [Related]
16. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
[No Abstract] [Full Text] [Related]
17. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
Inui M; Tanabe K; Ishikawa N; Tokumoto T; Harano M; Otsubo S; Suzuki K; Goya N; Yagisawa T; Nakazawa H; Fuchinoue S; Toma H
Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
[No Abstract] [Full Text] [Related]
18. Tacrolimus-based immunosuppression in pediatric renal transplantation.
Jordan ML; Shapiro R; Scantlebury V; Vivas C; Ellis D; Lombardozzi-Lane S; Starzl TE
Transplant Proc; 1999 Nov; 31(7A):29S-30S. PubMed ID: 10576039
[No Abstract] [Full Text] [Related]
19. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
Birkeland SA
Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
[TBL] [Abstract][Full Text] [Related]
20. Impact of extreme donor age on the outcome of living-related donor kidney transplantation.
Uslu A; Tokat Y; Ok E; Unsal A; Celik A; Yalaz S; Kaplan H
Transplant Proc; 1998 May; 30(3):734-7. PubMed ID: 9595078
[No Abstract] [Full Text] [Related]
[Next] [New Search]
